ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 82 filers reported holding ADICET BIO INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $867,940 | -36.6% | 633,533 | +12.4% | 0.00% | – |
Q2 2023 | $1,369,947 | -57.9% | 563,764 | -0.1% | 0.00% | – |
Q1 2023 | $3,251,272 | -92.0% | 564,457 | -87.6% | 0.00% | -100.0% |
Q4 2022 | $40,848,398 | +46.7% | 4,569,172 | +133.3% | 0.00% | -50.0% |
Q3 2022 | $27,847,000 | +300.8% | 1,958,265 | +311.5% | 0.00% | – |
Q2 2022 | $6,947,000 | -12.3% | 475,856 | +19.9% | 0.00% | – |
Q1 2022 | $7,923,000 | +38.3% | 396,768 | +21.2% | 0.00% | – |
Q4 2021 | $5,727,000 | +146.5% | 327,441 | +10.5% | 0.00% | – |
Q3 2021 | $2,323,000 | -10.1% | 296,247 | +17.9% | 0.00% | – |
Q2 2021 | $2,585,000 | +1786.9% | 251,197 | +2290.1% | 0.00% | – |
Q1 2021 | $137,000 | -36.9% | 10,510 | -32.0% | 0.00% | – |
Q4 2020 | $217,000 | +17.9% | 15,466 | 0.0% | 0.00% | – |
Q3 2020 | $184,000 | – | 15,466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |